Clinical Trial Update: A Real World Study of Sacituzumab Govitecan

View source ↗

Summary

Real-world study evaluating Sacituzumab Govitecan for metastatic breast cancer is currently recruiting at Fudan University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sacituzumab Govitecan (sacituzumab govitecan)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer Metastatic, Treatment Outcome | Status: RECRUITING